Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac
Links shared publicly online about this topic.
- 1,795total visits
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac
IRVINE, Calif. — Ista Pharmaceuticals has announced positive preliminary phase 3 results from the company's confirmatory clinical trial of a
View full resource at osnsupersite.com
Tags: Pharma, Phase 3 Clinical Trial, Clinical Trial
Most Recently Shared on August 27, 2009 at 3:24 am By:
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac: http://ow.ly/lplZ
Also Shared By:
ISTA Pharmaceuticals Announces Positive Results for Xibrom™ Once-Daily
eyedocnews.com — “ISTA Pharmaceuticals, Inc. has announced positive Phase 3 results from a confirmatory clinical trial with Xibrom™ (bromfenac ophthalmic solution) 0.09% QD in the treatment of ocular inflammation and pain after cataract surgery.” View full resource at eyedocnews.com
Most Recently Shared on August 30, 2009 at 10:37 pm By:
Dr. Ari Weitzner Doctor, Ophthalmologist, and Physician
Discuss: ISTA Pharmaceuticals Announces Positive Results for Xibrom: By Dr. Dominique Walton BrooksISTA .. http://bit.ly/14srOS
Advertisement
Eye Doctor
@HelpMyDryEyes
@OSNSuperSite Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac: http://ow.ly/lplZ
1 year ago...